Anakinra, an IL-1 inhibitor and an FDA-approved injectable medication to treat rheumatoid arthritis, was proposed to reduce pelvic pain caused by endometriosis in a human pilot study; however, no results were posted after the study (74). The gene discussed is IL1B; the disease is endometriosis.